Welcome : Guest

ORGAN AND TISSUE TRANSPLANTATION - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Organ and Tissue Transplantation in Volume Terms (Number of Procedures). The Global and Regional markets (except the US) are analyzed by the following Product Segments: Heart, Kidney, Liver, Pancreas, and Lung, and Corneal Transplantation. The US market is analyzed by the following Segments: Organ Type (In Volume and Value) - Heart, Kidney, Liver, Pancreas, Lung, and Intestine; Tissue Type (Volume Only) - Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts; and Bone Graft Transplantation (Volume Only) -By Graft Type: Autologous Graft, Allograft, and Other Materials; and By Application Type: General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 19 companies including many key and niche players such as -

Acelity L.P. Inc.
CryoLife, Inc.
Exactech, Inc.
Dr. Franz Köhler Chemie GmbH
Organogenesis, Inc.
Organ Recovery Systems

Click here to request a full list of companies covered in the report...

Code: MCP-1572
Price: $4950
Companies: 19
Pages: 275
Date: March 2018
Market Data Tables: 143
  Status: * New Report



TABLE OF CONTENTS


  ORGAN AND TISSUE TRANSPLANTATION (Complete Report) Pages : 275   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Market Outlook.....II-11$100
   Current & Future Analysis.....II-21$100
   A Review of Organ Donors Worldwide.....II-3
Table 1: World Deceased Organ Donors (2016 & 2017): Number of Donors Per Million Population (PMP) for Leading Countries (includes corresponding Graph/Chart).....II-3
1$350
   Table 2: World Living Organ Donors (2016 & 2017): Number of Donors Per Million Population (PMP) for Leading Countries (includes corresponding Graph/Chart).....II-41$350
   Table 3: World Deceased Organ Donors by Type (2011, 2013 & 2015): Percentage Breakdown of Number of Donors for DCD and DBD (includes corresponding Graph/Chart).....II-5
Demand and Supply Imbalance.....II-5
Measures to Address Organ Shortage .....II-5
1$350
   Cardiac Arrest Death Patients: The Untapped Potential Donors.....II-6
Table 4: World Organ Donors After Circulatory Death (2016): Number of Donors Per Million Population (PMP) for Leading Countries (includes corresponding Graph/Chart).....II-6
Donation after Circulatory Death – Rife with Ethical Issues.....II-6
1$350
   Transplantation – Expenditure and Regional Variations.....II-7
Table 5: US Organ Transplantation Charges - Total Billed Charges per Transplant by Type (2014) (includes corresponding Graph/Chart).....II-7
1$350
   Bone Grafts: An Overview.....II-8 1$100
   Table 6: Fractures by Age Group (2017E): Percentage Share Breakdown of Number of Fractures by Age Group (includes corresponding Graph/Chart).....II-9
Orthopedic Grafts – Regional Market Variations.....II-9
1$350
   Combined Organ Transplantation – Gaining Attention.....II-10
Illegal Organ Trafficking – A Risky Proposition.....II-10
Transplant Tourism – Creating Brighter Avenues.....II-10
1$100
   Graying Population and Chronic Diseases Surge Need for Transplants.....II-11
Table 7: Global Aging Population (in Thousands) by Age Group: 1975-2050 (includes corresponding Graph/Chart).....II-11
1$350
   Table 8: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart).....II-121$350
   Table 9: Global Population Statistics for the 60+ Age Group by Region (2017) (includes corresponding Graph/Chart).....II-131$350
   Table 10: Global Life Expectancy at Birth (Years) by Geographic Region: 1950-2050 (includes corresponding Graph/Chart).....II-141$350
   Table 11: Life Expectancy for Select Countries in Number of Years: 2016 (includes corresponding Graph/Chart).....II-151$350
   Optimization Strategies for Organs Catch Attention and Supply-Demand Gap
  Widens.....II-16
Advent of Innovative Devices Mitigate Chances of Organ Damages.....II-16
1$100
   Investment Opportunities Rise for Allied Fields as Organ Transplantation Market
  Grows.....II-17
Shortage of Organs Propels Research on Xenotransplantation.....II-17
2$200
   A Peek into the Organ Transplant Immunosuppressants Market.....II-19
Market to Come Under Tremendous Pressure.....II-19
1$100
   Rising Incidences of Degenerative Intervertebral Disc Diseases Promote Tissue
  Transplantation.....II-20
1$100
   Table 12: % of Women Affected by Osteoporosis (includes corresponding Graph/Chart).....II-21
Fetal Tissue for Bionic Devices – Assuming Importance.....II-21
LVADs – Gaining Significance for Impending Heart Transplants.....II-21
1$350
   Synthetic Bone Graft – The Latest Trend.....II-22
Stem Cell Therapies – Expanding the Horizon of Transplantation.....II-22
1$100
   Rising Cancer Incidence to Drive Stem Cell Transplants.....II-23 1$100
   Table 13: Global Cancer Incidence (2015): Number of New Cancer Cases in Thousands by Type and Gender (includes corresponding Graph/Chart).....II-241$350
   Table 14: Global Cancer Mortality (2015): Number of Cancer Related Deaths in Thousands by Type and Gender (includes corresponding Graph/Chart).....II-251$350
   Demineralized Bone Matrix (DBM): Strong Growth but Tough Competition.....II-26
Bone Morphogenetic Protein – Safety Concerns Affect Growth Prospects.....II-26
Dental Bone Grafting – A High Potential Market.....II-26
1$100
   Table 15: Dental Tissue & Bone Regeneration Materials Market (2015): Percentage Share Breakdown by Segment for Allografts, Synthetics, and Xenografts (includes corresponding Graph/Chart).....II-27
Key Recent Technological Innovations.....II-27
3-D Bioprinting.....II-27
1$350
   Preloaded Corneal Tissue Cartridges.....II-28
Lung Perfusion Technology.....II-28
1$100
   Organ Rejection – A Major Barrier to Transplantation.....II-29
Scarcity of Donor Organs – A Stumbling Block in Organ Transplantation.....II-29
Other Issues for Organ Transplantation.....II-29
Ethical Concerns in Transplants.....II-29
1$100
   Bioethical Issues Hinder Organ Donation Process.....II-30
Lack of Requisite Expertise – Hindering Implantation Process.....II-30
Corneal Transplantation in Developing Countries: Key Challenges.....II-30
1$100
   Organ and Tissue Transplantation.....II-31
Organ Transplantation.....II-31
Heart Transplantation.....II-31
1$100
   Heart Diseases and Disorders.....II-32
Post-Operative Complications and Consequences of Heart Transplants.....II-32
Bleeding.....II-32
Infection.....II-32
Arrhythmia.....II-32
Heart Attack.....II-32
1$100
   Coronary Artery Disease.....II-33
Respiratory Dysfunction.....II-33
Renal Dysfunction.....II-33
Graft Rejection and Dysfunction.....II-33
Death.....II-33
Kidney Transplantation.....II-33
1$100
   Kidney Disorders and Diseases.....II-34
Donor Evaluation.....II-34
Waiting List.....II-34
Surgery/Post-Operation.....II-34
Post-Operative Supervision and Issues.....II-34
1$100
   Liver Transplantation.....II-35
Liver Disorders and Diseases.....II-35
1$100
   Pancreas Transplantation.....II-36
Post-Operative Complications and Consequences of Pancreas Transplants.....II-36
1$100
   Small Intestine Transplantation.....II-37
Intestine Disorders and Diseases.....II-37
Lung Transplantation.....II-37
Lung Diseases and Disorders.....II-37
1$100
   Lung Patients Survival Statistics.....II-38
Heart-and-Lung Transplantation.....II-38
Tissue Transplantation.....II-38
Types of Grafts.....II-38
Autograft.....II-38
1$100
   Allograft/Homograft.....II-39
Transplant Tolerance.....II-39
Isograft.....II-39
Xenograft.....II-39
1$100
   Corneal Transplantation.....II-40
Penetrating Keratoplasty.....II-40
1$100
   Lamellar (Non-Penetrating) Keratoplasty.....II-41
Aftercare.....II-41
Risks Associated with Corneal Transplants.....II-41
Transplantation Outcomes.....II-41
Morbidity and Mortality Rates.....II-41
1$100
   Alternatives.....II-42
Blood Stem Cells.....II-42
Peripheral Blood Stem Cell Transplant.....II-42
Umbilical Cord Blood Stem Cell Transplant.....II-42
Bone Marrow and Hematopoietic Stem Cells.....II-42
Bone and Tissue Transplantation.....II-42
1$100
   Bone Marrow Transplants.....II-43
Stem Cell Therapy.....II-43
1$100
   Human Heart Valves.....II-44
Atrioventricular Valves.....II-44
Mitral Valve.....II-44
Tricuspid Valve.....II-44
Semilunar Valves.....II-44
1$100
   Aortic Valve.....II-45
Pulmonic Valve.....II-45
Pathology of Valves.....II-45
Prosthetic Heart Valves.....II-45
1$100
   Prosthetic Mechanical Valve.....II-46
Advantages.....II-46
Disadvantages.....II-46
Prosthetic Biologic Valve.....II-46
1$100
   Advantages.....II-47
Disadvantages.....II-47
Fetal Cells.....II-47
Fetal Tissue for Transplantation.....II-47
1$100
   Storage Duration Time.....II-48
Storage Time Period for Organs and Tissues.....II-48
Cold Ischemia Time.....II-48
Transplantation Immunology.....II-48
Acute Cellular Rejection.....II-48
1$100
   Chronic Rejection.....II-49
Post-Transplant Observations.....II-49
Types of Donors.....II-49
Alive Donors.....II-49
Related Donors.....II-49
1$100
   Good Samaritans.....II-50
Rewarded/Forced Donors.....II-50
Deceased Donors.....II-50
Directed / Allocated.....II-50
Organs and Tissues Transplanted by Type of Donor.....II-50
1$100
   Organ/Tissue Donation and Eligibility Criteria.....II-51
Factors Considered for Matching Recipients to Donor Organs.....II-51
Testing.....II-51
Blood Typing.....II-51
1$100
   Tissue Typing.....II-52
Histocompatibility – A Major Barrier for Organ Transplantation.....II-52
1$100
   Transplantation – Safety Requirements.....II-53
Waiting List.....II-53
Active Waiting List Patients.....II-53
Inactive Waiting List Patients.....II-53
History.....II-53
2$200
   Major Milestones in Organ Transplantation.....II-551$100
   Artificial Organs Revolutionize Medical Technology Industry.....II-56
Artificial Organs.....II-56
Categorization of Artificial Organs.....II-56
1$100
   External Artificial Organs.....II-57
Internal or Implantable Artificial Devices.....II-57
Artificial Heart.....II-57
Total Artificial Heart (TAH).....II-57
Ventricle Assist Device (VAD).....II-57
Right Ventricular Assist Systems (RVAS).....II-57
Left Ventricular Assist Systems (LVAS).....II-57
1$100
   Select Ventricular Assist Devices.....II-58
Artificial Kidney (Dialyzer).....II-58
Limitations of Artificial Kidney.....II-58
1$100
   Artificial Liver.....II-59
Select Liver Assist Devices.....II-59
Categorization of Liver Devices.....II-59
Mechanical Systems.....II-59
Bio-Artificial Systems.....II-59
Artificial Pancreas.....II-59
1$100
   Artificial Lungs (Oxygenator).....II-60
Types of Artificial Lung.....II-60
Artificial Cornea.....II-60
Keratoprostheses.....II-60
Tissue Engineered Corneas.....II-60
Artificial Skin/Skin Replacement Products.....II-60
AlloDerm Regenerative Tissue Matrix.....II-60
1$100
   Apligraf.....II-61
Cymetra Micronized AlloDerm Tissue.....II-61
Dermagraft.....II-61
Epicel.....II-61
Integra Products.....II-61
OrCel.....II-61
TransCyte.....II-61
1$100
   Core Competitive Factors.....II-62
Market Outlook for Artificial Organs.....II-62
1$100
   Organ Preservation Solutions.....II-63
Celsior Solution.....II-63
Collins Solution.....II-63
Euro Collins Solution.....II-63
Custodiol® HTK Solution.....II-63
Hypothermosol.....II-63
1$100
   ViaSpan.....II-64
Immunosuppressant Drugs.....II-64
Antibody Products for Treatment of Organ Transplant Rejection.....II-64
Antithymocyte Globulin.....II-64
ATGAM.....II-64
1$100
   Thymoglobulin.....II-65
Therapeutic Antibody Products.....II-65
Antiproliferative Agents.....II-65
Azathioprine.....II-65
CellCept.....II-65
Certican.....II-65
Myfortic.....II-65
Calcineurin Inhibitors.....II-65
1$100
   Cyclosporine.....II-66
Gengraf.....II-66
Neoral.....II-66
Prograf (Tacrolimus).....II-66
TOR Inhibitors.....II-66
Side Effects of Immunosuppression Therapy.....II-66
1$100
   Transplant Center.....II-67
Organ Procurement Organization (OPO).....II-67
Health Resources and Services Administration (HRSA).....II-67
Division of Transplantation (DoT).....II-67
United Network for Organ Sharing (UNOS).....II-67
Organ Procurement and Transplantation Network (OPTN).....II-67
1$100
   University Renal Research and Education Association (URREA).....II-68
Scientific Registry of Transplant Recipients (SRTR).....II-68
Funding Sources.....II-68
Patient Education and Advocacy Organizations.....II-68
1$100
   Legal Framework for Transplantation.....II-69
Legislation Covering Organ Transplant.....II-69
1$100
   Organ Transplantation and Ethics.....II-701$100
   Royal Biologics Launches Demineralized Bone Matrix Product, MAXX-Fuse.....II-71
Extremity Medical Launches Next-Gen Viable Cell Bone Graft, BioFuse.....II-71
AlloSource Launches Two New Demineralized Cortical Fiber Allografts.....II-71
Immucor Launches Kidney Solid Organ Response Test, kSORT.....II-71
1$100
   Exactech Merges with TPG Capital.....II-72
CryoLife Acquires JOTEC.....II-72
SeaSpine Receives FDA Approval for OsteoBallast™ DBM in Resorbable Mesh.....II-72
Medtronic Receives FDA Approval for Endurant™ II/IIs Stent Graft System.....II-72
Organogenesis Acquires NuTech Medical.....II-72
Allergan to Acquire Acelity’s LifeCell Business Unit.....II-72
1$100
   CryoLife Acquires On-X Life Technologies.....II-73
MiMedx Group Acquires Stability Biologics.....II-73
1$100
   Acelity L.P. Inc. (USA).....II-74
CryoLife, Inc. (USA).....II-74
Exactech, Inc. (USA).....II-74
1$100
   Dr. Franz Köhler Chemie GmbH (Germany).....II-75
Organogenesis, Inc. (USA).....II-75
1$100
   Organ Recovery Systems (USA).....II-76
Organ Transport Systems (USA).....II-76
XVIVO Perfusion AB (Sweden).....II-76
1$100
   Table 16: World Recent Past, Current & Future Analysis for Organ Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-771$350
   Table 17: World Historic Review for Organ Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-781$350
   Table 18: World 14-Year Perspective for Organ Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-791$350
   Table 19: World Recent Past, Current & Future Analysis for Heart Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-801$350
   Table 20: World Historic Review for Heart Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-811$350
   Table 21: World 14-Year Perspective for Heart Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-821$350
   Table 22: World Recent Past, Current & Future Analysis for Kidney Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-831$350
   Table 23: World Historic Review for Kidney Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-841$350
   Table 24: World 14-Year Perspective for Kidney Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-851$350
   Table 25: World Recent Past, Current & Future Analysis for Liver Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-861$350
   Table 26: World Historic Review for Liver Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-871$350
   Table 27: World 14-Year Perspective for Liver Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-881$350
   Table 28: World Recent Past, Current & Future Analysis for Pancreas Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-891$350
   Table 29: World Historic Review for Pancreas Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-901$350
   Table 30: World 14-Year Perspective for Pancreas Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-911$350
   Table 31: World Recent Past, Current & Future Analysis for Lung Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-921$350
   Table 32: World Historic Review for Lung Transplantation by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-931$350
   Table 33: World 14-Year Perspective for Lung Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-941$350
   Table 34: World Recent Past, Current & Future Analysis for Corneal Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-951$350
   Table 35: World Historic Review for Corneal Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-961$350
   Table 36: World 14-Year Perspective for Corneal Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-971$350
   A. Market Analysis.....III-1
Current & Future Analysis.....III-1
Organ Transplant Sector Holds Growth Potential.....III-1
1$75
   Table 37: Number of Transplants and Waiting List for Organ Transplantation in the US: 2005 & 2016 (In Thousands) (includes corresponding Graph/Chart).....III-2

Table 38: Organ Transplantation Donors in the US by Type (2016): Number of Organ Donors in Thousands and Percentage Share Breakdown for Living and Deceased (includes corresponding Graph/Chart).....III-2
1$200
   Table 39: Organs Donated for Transplantation in the US by Type (2016): Number of Donated Organs in Thousands and Percentage Share Breakdown for Living and Deceased (includes corresponding Graph/Chart).....III-3

Table 40: US Deceased Donors by Ethnicity (2016): Percentage Breakdown of Number of Donors for African America, Asian, Caucasian, Hispanic and Others (includes corresponding Graph/Chart).....III-3
1$200
   Table 41: Transplant Recipients in the US by Ethnicity (2016): Percentage Breakdown of Number of Transplants for African America, Asian, Caucasian, Hispanic and Others (includes corresponding Graph/Chart).....III-4
Waiting List for Organ Transplants in the US.....III-4
Table 42: Organ Transplant Waiting List in the US by Ethnicity (2017): Percentage Breakdown of Number of People on Waiting List for African America, Asian, Caucasian, Hispanic and Others (includes corresponding Graph/Chart).....III-4
1$200
   Select Market Trends.....III-5
Rising Incidence of ESRD in the US: A Business Case for Kidney Transplants.....III-5
Innovative Education Programs Contribute to Higher Organ Donors.....III-5
1$75
   Awareness Programs to Address Shortage of Minority Donors.....III-6
US Organ Procurement Organizations by State.....III-6
1$75
   KPD Enables Compatibility Factor for Kidney Transplants.....III-71$75
   Tissue Transplantation in the US.....III-8
Dental Bone Graft Substitutes Market: An Overview.....III-8
Regulatory Challenges Limit Growth in the US Orthopedic Biomaterials Market.....III-8
1$75
   Rising Incidence of Degenerative Intervertebral Disc Diseases – Opportunity
  Indicators for Bone Grafts.....III-9
Osteoporosis.....III-9
Table 43: Osteoporosis and Low Bone Mass Population in the US: 2010 & 2020 (includes corresponding Graph/Chart).....III-9
1$200
   Table 44: Breakdown of Osteoporotic Fractures by Site in the US (includes corresponding Graph/Chart).....III-10
Regulatory Bodies.....III-10
The United Network for Organ Sharing.....III-10
The American Association of Tissue Banks (AATB).....III-10
1$200
   Accredited Banks from Select US States.....III-111$75
   Eye Banks from Select US States.....III-121$75
   National Organ Transplant Act (NOTA).....III-13
Good Tissue Practices.....III-13
Tissue Banking Regulation.....III-13
FDA Regulations on Xenograft.....III-13
DBM-based Products in US.....III-13
1$75
   Synthetic Bone Graft Substitutes.....III-14
Product Launches.....III-14
1$75
   Strategic Corporate Developments.....III-151$75
   Select Key Players.....III-162$150
   B. Market Analytics.....III-18
By Value Sales.....III-18
Table 45: The US Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-18
1$200
   Table 46: The US Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-191$200
   Table 47: The US 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Dollar Sales for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-201$200
   Table 48: The US Recent Past, Current & Future Analysis for Cornea Transplantation Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-211$200
   Table 49: The US Historic Review for Cornea Transplantation Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-221$200
   By Number of Procedures.....III-23
Table 50: The US Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-23
1$200
   Table 51: The US Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-241$200
   Table 52: The US 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-251$200
   Table 53: The US Recent Past, Current & Future Analysis for Tissue Transplantation by Tissue Type - Cornea, Heart, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-261$200
   Table 54: The US Historic Review for Tissue Transplantation by Tissue Type - Cornea, Heart, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-271$200
   Table 55: The US 14-Year Perspective for Tissue Transplantation by Tissue Type - Percentage Breakdown of Number of Procedures for Cornea, Heart, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-281$200
   Table 56: The US Recent Past, Current & Future Analysis for Bone Graft Transplantation by Graft Type - Autologous Graft, Allograft and Other Materials Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-291$200
   Table 57: The US Historic Review for Bone Graft Transplantation by Graft Type - Autologous Graft, Allograft and Other Materials Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-301$200
   Table 58: The US 14-Year Perspective for Bone Graft Transplantation by Graft Type - Percentage Breakdown of Number of Procedures for Autologous Graft, Allograft and Other Materials Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-311$200
   Table 59: The US Recent Past, Current & Future Analysis for Bone Graft Transplantation by Application - General Orthopedics, Spinal Fusions and Cranio/Maxillofacial Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-321$200
   Table 60: The US Historic Review for Bone Graft Transplantation by Application - General Orthopedics, Spinal Fusions and Cranio/ Maxillofacial Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-331$200
   Table 61: The US 14-Year Perspective for Bone Graft Transplantation by Application - Percentage Breakdown of Number of Procedures for General Orthopedics, Spinal Fusions and Cranio/ Maxillofacial Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-341$200
   A. Market Analysis.....III-35
Current & Future Analysis.....III-35
Canadians More Receptive to Organ Transplants.....III-35
Table 62: Organ Transplants in Canada by Province (2016): Percentage Breakdown of Number Transplants for Alberta, British Columbia, Manitoba, Ontario, Quebec, Saskatchewan and Others (includes corresponding Graph/Chart).....III-35
1$200
   Table 63: Combination Organ Transplants in Canada by Province (2016): Percentage Breakdown of Number Transplants for Alberta, British Columbia, Ontario and Quebec (includes corresponding Graph/Chart).....III-36

Table 64: Combination Organ Transplants in Canada by Combination (2016): Percentage Breakdown of Number Transplants for Heart-Lung, Kidney-Liver, Kidney-Pancreas, Liver-Small Intestine, Multi-visceral Cluster and Others (includes corresponding Graph/Chart).....III-36
1$200
   Organ Donors.....III-37
Table 65: Canadian Organ Donors by Donor Type - Deceased and Living for Years 2012-2016 (includes corresponding Graph/Chart).....III-37

Table 66: Living Donor Transplants in Canada by Organ (2016): Percentage Breakdown of Number of Transplants for Kidney, Kidney Paired Donation, and Liver (includes corresponding Graph/Chart).....III-37
1$200
   Table 67: Deceased Organ Donations in Canada (2016): Organ Donations Per Million Population (PMP) by Province (includes corresponding Graph/Chart).....III-38
Waiting List.....III-38
Table 68: Organ Transplantation Waiting List in Canada (2016): Number of Patients on Waiting List by Organ Type – Heart, Kidney, Liver, Lung, Pancreas and Others (includes corresponding Graph/Chart).....III-38
1$200
   Table 69: Waiting List Trends in Recent Past (2012-2016): Number of Patients on Waiting List for Heart, Kidney, Liver and Lung Transplantation (includes corresponding Graph/Chart).....III-39

Table 70: Combination Organ Transplants Waiting List in Canada by Combination (2016): Percentage Breakdown of Number Transplants for Heart-Lung, Heart-Liver, Kidney-Heart, Kidney-Pancreas, Kidney-Liver, Liver-Lung, Liver-Small Intestine and Others (includes corresponding Graph/Chart).....III-39
1$200
   Favorable Growth Prospects in Bone Graft Substitutes Market.....III-40
B. Market Analytics.....III-40
Table 71: Canadian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-40
1$200
   Table 72: Canadian Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-411$200
   Table 73: Canadian 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-421$200
   A. Market Analysis.....III-43
Current & Future Analysis.....III-43
Terumo Corporation (Japan) – A Key Player.....III-43
1$75
   B. Market Analytics.....III-44
Table 74: Japanese Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-44
1$200
   Table 75: Japanese Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-451$200
   Table 76: Japanese 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-461$200
   A. Market Analysis.....III-47
Current & Future Analysis.....III-47
Key Statistics.....III-47
Table 77: European Organ Transplantation Rate in Per Million Population for Leading Countries: 2016 (includes corresponding Graph/Chart).....III-47
1$200
   Table 78: European Deceased Organ Donors Per Million Population (PMP) in Select Leading Countries: 2016 (includes corresponding Graph/Chart).....III-481$200
   Table 79: European Living Organ Donors Per Million Population (PMP) in Select Leading Countries: 2016 (includes corresponding Graph/Chart).....III-49
Policy Changes – Key to Bridge Variability in Kidney Donors and Transplants across
  Europe.....III-49
1$200
   B. Market Analytics.....III-50
Table 80: European Recent Past, Current & Future Analysis for Organ Transplantation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-50
1$200
   Table 81: European Historic Review for Organ Transplantation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-511$200
   Table 82: European 14-Year Perspective for Organ Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-521$200
   Table 83: European Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-531$200
   Table 84: European Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-541$200
   Table 85: European 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-551$200
   A. Market Analysis.....III-56
Current & Future Analysis.....III-56
Organ Donation Statistics.....III-56
Table 86: Organ Donations in France (2016): Number of Donors and PMP by Type - Deceased and Living (includes corresponding Graph/Chart).....III-56
1$200
   B. Market Analytics.....III-57
Table 87: French Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-57
1$200
   Table 88: French Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-581$200
   Table 89: French 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-591$200
   A. Market Analysis.....III-60
Current & Future Analysis.....III-60
Strategic Corporate Development.....III-60
Key Player.....III-60
1$75
   B. Market Analytics.....III-61
Table 90: German Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-61
1$200
   Table 91: German Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-621$200
   Table 92: German 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-631$200
   A. Market Analysis.....III-64
Current & Future Analysis.....III-64
Surge in Organ Transplants.....III-64
Table 93: Organ Donations in Italy (2016): Number of Donors and PMP by Type - Deceased and Living (includes corresponding Graph/Chart).....III-64
1$200
   B. Market Analytics.....III-65
Table 94: Italian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-65
1$200
   Table 95: Italian Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-661$200
   Table 96: Italian 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-671$200
   A. Market Analysis.....III-68
Current & Future Analysis.....III-68
Organ Transplantation in the UK.....III-68
Key Statistics.....III-68
Table 97: Organ Donation in the UK by Type: Number of Deceased and Living Donors for Years 2012-13 through 2016-17 (includes corresponding Graph/Chart).....III-68
1$200
   Table 98: Deceased Organ Donors in the UK by Organ and Country (2017): Number of Organ Donors for England, Scotland, Wales and Northern Ireland (includes corresponding Graph/Chart).....III-691$200
   Table 99: Organ Transplantation Waiting List in the UK by Organ and Country (2017): Number of People on Waiting List for England, Scotland, Wales and Northern Ireland (includes corresponding Graph/Chart).....III-701$200
   Table 100: Deceased Solid Organ Donors in the UK by Organ Type and Type of Death: 2016-17 (includes corresponding Graph/Chart).....III-711$200
   Table 101: Organs Retrieved per Deceased Donor by Country (2016-17): Average Number of Organs Retrieved from Deceased Patients of all Ages for England, Wales, Scotland and Northern Ireland (includes corresponding Graph/Chart).....III-72

Table 102: Organ Donors in the UK by Age Group and Death Type: 2016-17 (includes corresponding Graph/Chart).....III-72
1$200
   The UK Organ Transplantation System: An Overview.....III-73
B. Market Analytics.....III-73
Table 103: UK Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-73
1$200
   Table 104: UK Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-741$200
   Table 105: UK 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-751$200
   A. Market Analysis.....III-76
Current & Future Analysis.....III-76
Spain - A Global Leader in Organ Donation.....III-76
1$75
   B. Market Analytics.....III-77
Table 106: Spanish Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-77
1$200
   Table 107: Spanish Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-781$200
   Table 108: Spanish 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-791$200
   A. Market Analysis.....III-80
Current & Future Analysis.....III-80
Organ Transplantations Show a Downward Trend in Russia.....III-80
Organ Donation Statistics.....III-80
Table 109: Organ Donations in Russia (2016): Number of Donors and PMP by Type – Deceased and Living (includes corresponding Graph/Chart).....III-80
1$200
   B. Market Analytics.....III-81
Table 110: Russian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-81
1$200
   Table 111: Russian Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-821$200
   Table 112: Russian 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-831$200
   A. Market Analysis.....III-84
Current & Future Analysis.....III-84
Turkey.....III-84
Table 113: Turkey - High PMP Numbers of Living Organ Donors/Transplants (includes corresponding Graph/Chart).....III-84
1$200
   Table 114: Organ Donations in Turkey (2016): Number of Donors by Type – Deceased and Living (includes corresponding Graph/Chart).....III-85
Akdeniz University – A World-Renowned Transplantation Center.....III-85
Strategic Corporate Development.....III-85
1$200
   Key Player.....III-861$75
   B. Market Analytics.....III-87
Table 115: Rest of European Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-87
1$200
   Table 116: Rest of European Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-881$200
   Table 117: Rest of European 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-891$200
   A. Market Analysis.....III-90
Current & Future Analysis.....III-90
Table 118: Asia-Pacific Deceased Organ Donor Per Million Population (PMP) by Country for 2013 & 2016 (includes corresponding Graph/Chart).....III-90

Table 119: Asia-Pacific Living Organ Donor Per Million Population (PMP) by Country for 2012, 2014 & 2016 (includes corresponding Graph/Chart).....III-90
1$200
   Thriving Orthopedic Biomaterials Market in Asia-Pacific.....III-91
Focus on Select Regions.....III-91
Australia – One of the Major Organ Transplant Markets in Asia-Pacific.....III-91
Key Facts on Organ and Tissue Transplantation in Australia.....III-91
Organ Transplantations Reach Record Highs.....III-91
1$75
   Table 120: Organ Donations in Australia (2016 & 2017): Number of Organ Donors by Type - Deceased (DBD and DCD) and Living (AKX and Others) (includes corresponding Graph/Chart).....III-921$200
   Table 121: Organs and Tissue Donor Volume in Australia by Type: 2017 (includes corresponding Graph/Chart).....III-93

Table 122: Deceased Organ Donors and Donor PMP in Australia by State: 2017 (includes corresponding Graph/Chart).....III-93
1$200
   Table 123: Organ Transplantations Volume in Australia by Organ: 2016 & 2017 (includes corresponding Graph/Chart).....III-94

Table 124: Tissue Donations in Australia (2016 & 2017): Number of Deceased Tissue Donations by Type - Musculoskeletal, Cardiovascular and Skin (includes corresponding Graph/Chart).....III-94
1$200
   Government Efforts Key for Improving Organ Donation Activity.....III-95
Government Mulls Easing Registration Process Further.....III-95
China.....III-95
Chinese Organ Transplant Market – Embroiled in Controversy.....III-95
1$75
   A New and Promising Legal Organ Transplantation Set Up Emergence in
  China.....III-96
1$75
   Transplantation Tourism in China.....III-97
Low Transplant Success Rate Due to Unskilled Professionals.....III-97
Illegal Activities for Harvesting Organs in China.....III-97
1$75
   Regulations on Organ Transplantation.....III-98
Regulations on Brain Death.....III-98
1$75
   India.....III-99
Organ Transplantation in India – Present Status.....III-99
Rise in Medical Tourism Drives Bone Grafts Market.....III-99
Aging Population Boosts the Indian Orthopedic Market.....III-99
The Current Status of Organ Donation and Transplantation.....III-99
1$75
   Overview of Renal Transplantation.....III-100
Structural Deficiencies Affecting Indian Organ Donation Space.....III-100
1$75
   Singapore.....III-101
Awareness Programs to Increase Living Kidney Donations in Singapore.....III-101
B. Market Analytics.....III-101
Table 125: Asia-Pacific Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-101
1$200
   Table 126: Asia-Pacific Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-1021$200
   Table 127: Asia-Pacific 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-1031$200
   A. Market Analysis.....III-104
Current & Future Analysis.....III-104
Dental Bone Graft Substitutes Market – Overview.....III-104
1$75
   Key Statistics.....III-105
Table 128: Latin American Deceased and Living Organ Donors Per Million Population (PMP) by Country: 2016 (includes corresponding Graph/Chart).....III-105
1$200
   B. Market Analytics.....III-106
Table 129: Latin American Recent Past, Current & Future Analysis for Organ Transplantation by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-106
1$200
   Table 130: Latin American Historic Review for Organ Transplantation by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-1071$200
   Table 131: Latin American 14-Year Perspective for Organ Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for Brazil and Rest of Latin America Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-1081$200
   Table 132: Latin American Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-1091$200
   Table 133: Latin American Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-1101$200
   Table 134: Latin American 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-1111$200
   A. Market Analysis.....III-112
Current & Future Analysis.....III-112
Brazil – A Major Transplant Market.....III-112
1$75
   B. Market Analytics.....III-113
Table 135: Brazilian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-113
1$200
   Table 136: Brazilian Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-1141$200
   Table 137: Brazilian 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-1151$200
   Market Analysis.....III-116
Table 138: Rest of Latin American Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-116
1$200
   Table 139: Rest of Latin American Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-1171$200
   Table 140: Rest of Latin American 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-1181$200
   Market Analysis.....III-119
Table 141: Rest of World Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-119
1$200
   Table 142: Rest of World Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed with Number of Procedures for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-1201$200
   Table 143: Rest of World 14-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-1211$200
  
Total Companies Profiled: 19

Region/Country Players

The United States 16 Europe 3 Germany 1 Rest of Europe 2
Click here to request a full table of contents and more details on this project.